LONDON, May 7, 2026 – Proskauer advised Grifols in connection with a cross-border multicurrency credit facility, consisting of syndicated term loans and a revolving credit facility, totaling approximately $5.3 billion (equivalent).
Grifols is a global healthcare company and leading producer of plasma-derived medicines based in Spain. The financing included a US dollar TLB tranche of $2.0 billion and a Euro TLB tranche of €1.25 billion, as well as a significantly upsized $2.0 billion RCF. Net proceeds were utilized to refinance existing debt, including the repayment of its existing Term Loan B, the redemption of its remaining senior secured notes due 2027, and the partial redemption of its senior secured notes due 2030.
The team was led by finance partners Jake Keaveny and Frank Oliver and included partners Court Tisdale and Peter Mason as well as counsel Morgan Hill and associates Adam Nowicki and Michael Malvenda (Capital Markets and Global Finance).
Proskauer worked with Osborne Clarke, the company’s European counsel, including Eduard Arruga, the head of Banking and Finance in Spain, counsel Victoria Bobo and associates Pablo Lopez and Alejandra Ilarza in Spain and partners Antje Günther and Olexiy Oleshchuk, senior associate Arsen Dutka, and associate Hriday Chawla in Germany.